Gerald P. McDole
Directeur/Membre du Conseil chez PALADIN LABS INC.
Fortune : 37 789 $ au 31/05/2024
Postes actifs de Gerald P. McDole
Sociétés | Poste | Début | Fin |
---|---|---|---|
PALADIN LABS INC. | Directeur/Membre du Conseil | 01/01/2004 | - |
Independent Dir/Board Member | 20/10/2011 | - | |
Canadian Healthcare Marketing Hall of Fame | Corporate Officer/Principal | 15/09/2010 | - |
Innovation Institute of Ontario | Directeur/Membre du Conseil | - | - |
Canadian Genetic Disease Network | Directeur/Membre du Conseil | - | - |
Historique de carrière de Gerald P. McDole
Anciens postes connus de Gerald P. McDole
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEDICURE INC. | Directeur/Membre du Conseil | 16/01/2004 | 31/01/2023 |
Independent Dir/Board Member | 16/01/2004 | 31/01/2023 | |
CIPHER PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 23/02/2004 | 06/02/2014 |
Président | 06/02/2014 | 09/08/2016 | |
Independent Dir/Board Member | 23/02/2004 | 09/08/2016 | |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - | 20/03/2007 |
Astra Pharmaceuticals, Inc. | Directeur Général | 01/01/1985 | 01/10/2003 |
President | 01/01/1985 | 01/10/2003 | |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Directeur Général | 01/01/1999 | 01/01/2003 |
President | 01/01/1999 | 01/01/2003 | |
░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░ | - | - |
░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
Formation de Gerald P. McDole
University of Manitoba | Undergraduate Degree |
Simon Fraser University | Masters Business Admin |
Statistiques
Internationale
Canada | 17 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 8 |
President | 4 |
Independent Dir/Board Member | 3 |
Sectorielle
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
CIPHER PHARMACEUTICALS INC. | Health Technology |
MEDICURE INC. | Health Technology |
Entreprise privées | 13 |
---|---|
Paladin Labs, Inc.
Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Health Technology |
Canadian Genetic Disease Network | |
Innovation Institute of Ontario | |
Sti Technologies Ltd.
Sti Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services STI Technologies Ltd. provides marketing solutions to the health care industry. The firm's SmartTechnology platform allows stakeholders-manufacturers, pharmacies, prescribers, and payers to optimize their patient relationships. It offers solutions for pre-launch planning, brand adoption, market uptake, revenue optimization, retention and adherence, and loss of exclusivity. The company was founded by William B. Adams and Gregory Patey in 2001 and is headquartered in Halifax, Canada. | Commercial Services |
Astra Pharmaceuticals, Inc. | |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
Advanced Coronary Treatment Foundation | |
Institute of Health Economics | |
Canadian Stroke Network
Canadian Stroke Network Miscellaneous Commercial ServicesCommercial Services Canadian Stroke Network operates as a non-profit healthcare organization. The company was founded in 1999 and is headquartered in Ottawa, Canada. | Commercial Services |
Canadian Foundation for Pharmacy | |
Canadian Healthcare Marketing Hall of Fame | |
Astra Pharma, Inc. |
- Bourse
- Insiders
- Gerald P. McDole
- Expérience